About Quantificare
Quantificare is a Healthcare company based in San Mateo (United States) founded in 2001. Quantificare has raised $5.49 million across 1 funding round from investors including LBO France. Quantificare offers products and services including LifeViz Mini Pro, LifeViz Infinity Pro, LifeViz Mini, LifeViz Infinity, and LifeViz Body. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is QuantifiCare Inc. Its competitors include BioTelemetry, Molecular NeuroImaging and Imaging Endpoints.
Company details
Provider of 3D imaging systems and clinical trial services for aesthetic and medical applications. It offers a suite of 3D cameras for aesthetic practitioners to capture and track patient progress. Additionally, it provides comprehensive clinical trial imaging services, including study setup, image management, analysis, and independent panel review. These services support pharmaceutical, biotechnology, and medical device companies in evaluating treatment efficacy and safety. The companys offerings are designed to standardize imaging processes and improve the accuracy of assessments in both clinical and aesthetic settings.
- Headquarters San Mateo, United States
- SectorsHealthcare
- Email••••••••
- Website quantificare.com
- Social LinkedIn Facebook Instagram
- Legal Name Quantificare Inc.
- Total Equity Funding$5.49M (USD)
in 1 rounds
- Latest Funding Round$5.49M (USD), Series A
Sep 2019
- Investors
Products & Services of Quantificare
Quantificare offers a comprehensive portfolio of products and services, including LifeViz Mini Pro, LifeViz Infinity Pro, LifeViz Mini, LifeViz Infinity, and LifeViz Body.
3D system for facial and body imaging in aesthetic practices.
Advanced 3D photography for detailed patient consultations.
Compact tool for aesthetic image capture and analysis.
3D imaging device for comprehensive body assessments.
Specialized system for body and breast imaging applications.
Micro-level 3D imaging for clinical trial evaluations.
Services for study setup and image analysis in trials.
Funding Insights of Quantificare
Quantificare has successfully raised a total of $5.49M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.49 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.49M
- Total Rounds 1
- Last Round Series A — $5.49M
- First Round $5.49M
(Sep 2019)
- Investors Count 1
All 1 funding rounds of Quantificare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2019 | $5.49M | Series A | – | LBO France | – |
1 investors in total: 1 institutional.
Investors in Quantificare
Quantificare has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include LBO France.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are made in France and the US. | lbofrance.com | Paris, France |
Investor details for Quantificare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Quantificare
48 people are tracked at Quantificare (13 in leadership, 35 in team).
| Name | Role | Group |
|---|---|---|
Rodolfo Xavier | Sales Director Americas - 3d Systems | Leadership |
Nicolas Dapis | Chief Business Officer - Clinical Services | Leadership |
Monica Paula Ribeiro Justus | General Manager Operations | Leadership |
Dorian Kaiber | Director Sales & Marketing | Leadership |
Matilde Gonzalez | Research & Innovation Director | Leadership |
Angèle Estival - de Marcillac | Human Resources Director | Leadership |
Aurore Molnar | Marketing Director, 3D Systems | Leadership |
Aurelie Brunel | Chief Business Officer, 3D Systems | Leadership |
Stephane Boyeau | Chief Information Officer | Leadership |
Jean-Philippe Thirion | CEO | Leadership |
Robin Sinha | Chief Business Officer, Sales/Marketing/Business Development | Leadership |
Larry Buchner | US Clinical Sales Director | Leadership |
Johann Montay | Group Chief Financial Officer | Leadership |
Théo Galano Kaminski | Marketing And Sales Manager - North America | Team |
Angéline Guisset | Marketing & Communication Specialist EMEA | Team |
Asma Bensouici | Clinical Project Manager II | Team |
Samia Lattaoui | Clinical Data Coordinator | Team |
Pandora Spagnol | Clinical Project Manager II | Team |
Diogo Rozada | Area Business Manager | Team |
Bettina Bauchinger | Area Business Sales Manager - Central Europe | Team |
28 more people are available in the full profile.
Complete people profiles for Quantificare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Quantificare
2 dated milestones of Quantificare across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Quantificare is founded.
- Funding First funding round of $5.5M.
Competitors of Quantificare
Quantificare has 3 listed competitors in our database. They include BioTelemetry, Molecular NeuroImaging and Imaging Endpoints.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gobio.com | 1994 | Malvern, United States | 1,782 | Wireless products for monitoring health parameters are offered. | ||
| mnimaging.com | 2000 | New Haven, United States | 161 | Company offering specialized imaging services for neurodegenerative and neuropsychiatric disorders | ||
| imagingendpoints.com | 2009 | Scottsdale, United States | 56 | Offers medical imaging expertise for oncology research and clinical trials globally. |
Detailed competitors of Quantificare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Quantificare
The website of Quantificare (quantificare.com) receives about 7K visits a month.
- Monthly visits7K
▼ 44.1% vs previous month
Websites whose visitors overlap most with Quantificare. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| zimmer.de | 100% | 16.8K | #1,500,128 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Quantificare (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Quantificare
Complete news archive for Quantificare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quantificare
Quantificare was founded in 2001 and raised its 1st funding round 18 years after it was founded.
Quantificare is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Quantificare is a funded company, having raised a total of $5.49M across 1 funding round to date. The company's 1st funding round was a Series A of $5.49M, raised on Sep 2019.
Provider of 3D imaging systems and clinical trial services for aesthetic and medical applications. It offers a suite of 3D cameras for aesthetic practitioners to capture and track patient progress. Additionally, it provides comprehensive clinical trial imaging services, including study setup, image management, analysis, and independent panel review. These services support pharmaceutical, biotechnology, and medical device companies in evaluating treatment efficacy and safety. The companys offerings are designed to standardize imaging processes and improve the accuracy of assessments in both clinical and aesthetic settings.
Quantificare's top competitors include BioTelemetry, Molecular NeuroImaging and Imaging Endpoints.
Quantificare offers LifeViz Mini Pro, LifeViz Infinity Pro, LifeViz Mini, LifeViz Infinity, and 3 more products and services.
Quantificare has 1 investor. Key investors include LBO France.
Quantificare operates through Quantificare Inc..